Skip to main content
. 2021 Sep 8;84:102476. doi: 10.1016/j.janxdis.2021.102476

Table 1.

Characteristics and Symptom Frequencies of PTE Group (COVID-19-related and Other).

Variable COVID-19 (n = 1838) Other (n = 5196)
Age 39.65 (15.15) 38.04 (14.05)
Gender (Female) 1345 (73.18) 3863 (74.35)
Psychiatric History (Yes) 482 (26.22) 1756 (33.80)
UN Region
Africa 94 (5.52) 174 (3.44)
Latin America and Caribbean 334 (18.62) 496 (9.82)
North America 118 (6.58) 399 (7.90)
Eastern Asia 164 (9.14) 460 (9.10)
South-Eastern Asia 270(15.05) 234 (4.63)
Southern Asia 64 (3.57) 106 (2.10)
Western Asia 194 (10.81) 513 (10.15)
Eastern Europe 133 (7.41) 612 (12.11)
Northern Europe 24 (1.34) 213 (4.22)
Southern Europe 194 (10.81) 859 (17.00)
Western Europe 185 (10.31) 890 (17.61)
Australia and New Zealand 20 (1.11) 97 (1.92)
GPS symptoms (endorsed)
Nightmares 854 (46.46) 2348 (45.19)
Avoidance 1037 (56.42) 2781 (53.52)
Hypervigilance 1083 (58.92) 2288 (44.03)
Numbing 943 (51.31) 2375 (45.71)
Guilt 722 (39.28) 2319 (44.63)
Worthlessness 769 (41.84) 2243 (44.17)
Anger 682 (37.11) 1923 (37.01)
Anxiety 1365 (74.27) 3476 (66.90)
Worry 1068 (58.11) 2672 (51.42)
Depression 1154 (62.79) 3072 (59.12)
Anhedonia 1072 (58.32) 2638 (50.77)
Insomnia 1037 (58.42) 2778 (53.46)
Self-harm 133 (7.24) 481 (9.26)
Derealization 630 (34.28) 1346 (25.90)
Depersonalization 278 (15.13) 856 (16.47)
Substance use 473 (25.73) 1529 (29.43)
Other problems 963 (52.39) 2684 (51.66)

Note. Age presented as M (SD); all other variables presented as n (%).